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Food-borne salmonellosis is an important public health concern worldwide.
The objective of this study was to characterize the epidemiological patterns and antimicrobial resistance profile of
clinical Salmonella enterica isolates sent to the National Reference Laboratory for Gastrointestinal Infections of the
National Institute of Health (INSA), between January 2014 and December 2017.
MATERIAL and METHODS
Serotyping
•1124 clinical isolates
•Kauffmann-White-Le Minor scheme
Antimicrobial susceptibility
•969 clinical isolates (2015-2017)
•Disk diffusion according to EUCAST guidelines
Multiple-Locus Variable number tandem repeat Analysis (MLVA) and Whole Genome Sequencing (WGS) was
performed for outbreak identification
RESULTS
Salmonella serotype diversity
Overall, 68 different serotypes were identified between 2014 and 2017.
 The most frequent serotypes were S.4,5:i:-, S.Enteritidis, S.Typhimurium, S.Rissen, S.Typhi, and S.Stanley (Fig. 1) and
accounted for 87.2% of the isolates received.
 12.8% cases (n=144) were associated to infection by uncommon serotypes (Fig. 1).
 There was a significantly increase of S.Enteritidis from 2014 to 2017 (15.7% in 2014 to 37.6% in 2017) and a reduction of
S.4,5:i:- (38.6% in 2014 to 26.6% in 2017) (Fig. 2).
 88.6% (147/166) invasive infections were associated to non-typhoidal serotypes.
All the 25 cases of S.Typhi were acquired in endemic zones.
MLVA and NGS allowed the identification of several outbreaks of S.Enteritidis, particularly during 2016 and 2017.
 13.6% of the strains were received in 2014, 22.8% in 2015, 29.5% in 2016, and 34.1% in 2017.
 75.4% were isolated in faeces, 10.1% in blood, 1.1% in faeces and blood, and 3.6% in other biological products; 9.8% isolates
had no information.
 16.3% (166/1014) of the Salmonella isolates were associated with invasive infections.
 Salmonellosis was more frequent in the 0-5 years age group (37.5%), and males (54.8% ).
Antimicrobial susceptibility
Overall, 71.9% of the 969 isolates showed resistance to at least one antimicrobial agent and 39.9% showed multiple
antimicrobial resistance (resistance to ≥3 classes of antimicrobials).
 The highest resistance was observed in response to sulfamethoxazole, ampicillin and tetracycline, while moderate resistance
was observed in response to fluoroquinolones and trimethoprim. Response to cephalosporins and to carbapenems showed
a very low-level of resistance (Table 1).
Among the most frequent serotypes, S.4,5:i:- and S.Rissen showed the highest antimicrobial resistance (>95%) (Table 2).
Multiple antimicrobial resistances occur in either the most frequent serotypes (81.1% in S.4,5:i:-:, 51.1% in S.Typhimurium)
and in the less common (100% in S.Saintpaul , S.Ohio, S.Blockley and S.Essen) (Table 2).
 The most common antibiotic resistance pattern was AMP-TET-SMX.
Class of antimicrobials Antimicrobials
No. of resistant isolates (%) 
(n=969)
Penicilins
AMP 435 (44.6)
AMC 125 (12.9)
Cephalosporins
FOX 2 (0.2)
CAZ 3 (0.3)
CTX 3 (0.3)
FEP 1 (0.1)
CRO 3 (0.3)
Carbapenems MEM 1 (0.1)
Fluoroquinolones
NAL 127 (13.1)
PEF 130 (13.4)
Tetracyclines
TET 425 (43.9)
TGC 2 (0.2)
Aminoglycosides GEN 15 (1.5)
Miscellaneous agents
CHL 79 (7.8)
TMP 117 (12.1)
SMX 585 (60.4)
Macrolides AZM 15 (1.7)
AMP-Ampicillin; AMP-Amoxicillin- clavulanic acid; FOX-Cefoxitin; CAZ-Ceftazidime; CTX-Cefotaxime; FEP-
Cefepime; CRO-Ceftriaxone; MEM-Meropenem; NAL-Nalidix acid; PEF-Pefloxacin; TET-Tetracycline; TGC-
Tigecycline; GEN-Gentamicin; AZM-Azithromycin; CHL-Chloramphenicol; TMP-Trimethoprim; SMX-
Sulfamethoxazole.
Table 1. Antimicrobial resistance of Salmonella isolated in Portugal between 
2015-2017 
Although overall incidence rates of Salmonela did not change over time, trends and epidemiological factors differed remarkably by serotype. Indeed, there was a significantly increase of S.Enteritidis from 2014 to 2017 related to multi-country European
outbreaks.
 Continued surveillance of antimicrobial susceptibility is important due to the risk of resistance, particularly to fluoroquinolones and third-generation cephalosporins, and the high-level of multiple antimicrobial resistance.
A better understanding of Salmonella epidemiology will assist in responding to this disease and in planning and implementing prevention activities.
CONCLUSIONS
Table 2. Antimicrobial resistance of Salmonella serotypes isolated in Portugal 
between 2015-2017
Serotypes No.
% of resistant 
isolates 
% of Multiple 
antimicrobial 
resistances
S.4,5:i:- 312 96.8 81.1
S.Enteritidis 310 47.7 0.3
S.Typhimurium 178 76.4 51.1
S.Rissen 23 95.7 65.2
S.Typhi 23 56.5 4.3
S.Stanley 10 50.0 10.0
Others 113 61.9 20.4
Less common serotypes*
S.Infantis 4 75.0 25.0
S.Saintpaul 3 100 100
S.Schwerzengrund 3 100 66.7
S.London 3 66.7 33.3
S.Ohio 2 100 100
S.Blockley 1 100 100
S.Essen 1 100 100
*, Only some serotypes were showed.
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Figura 1: Salmonella serotypes identified in 1124 clinical isolates.
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Figura 2: Trend of Salmonella serotypes identified between 2014-2017.
